JPMorgan Starts Silk Road Medical (SILK) at Overweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
BofA/Merrill Lynch Starts Silk Road Medical (SILK) at Neutral
April 29, 2019 9:54 AM EDTBofA/Merrill Lynch initiates coverage on Silk Road Medical (NASDAQ: SILK) with a Neutral rating.
For an analyst ratings summary and ratings history on Silk Road Medical click here. For more ratings news on Silk Road Medical click here.
Shares of Silk Road Medical closed at $40.01 yesterday.
... MoreUPDATE: BMO Capital Starts Silk Road Medical (SILK) at Outperform
April 29, 2019 5:26 AM EDT(Updated - April 29, 2019 6:46 AM EDT)
(updated to add analyst comments)
BMO Capital analyst Joanne Wuensch initiates coverage on Silk Road Medical (NASDAQ: SILK) with a Outperform rating.
"Silk Roads ENROUTE TCAR system follows the classic transition from open to minimally invasive... More
Stifel Starts Silk Road Medical (SILK) at Buy
April 29, 2019 2:49 AM EDTStifel analyst Rick Wise initiates coverage on Silk Road Medical (NASDAQ: SILK) with a Buy rating and a price target of $44.00.
The analyst comments "Based on highly compelling clinical data, we believe over the next few years TCAR is poised to become standard of... More
